サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1652092

関節内補充療法の世界市場：市場規模・シェア・動向、業界分析 (製品別・最終用途別・地域別)、将来予測 (2025年～2034年)

Viscosupplementation Market Size, Share, Trends, Industry Analysis Report: By Product, End Use, and Region - Market Forecast, 2025-2034

出版日
ページ情報
英文 128 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
関節内補充療法の世界市場：市場規模・シェア・動向、業界分析 (製品別・最終用途別・地域別)、将来予測 (2025年～2034年)
出版日: 2025年01月01日
発行: Polaris Market Research
ページ情報: 英文 128 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、関節内補充療法の世界市場規模は2034年までに152億6,000万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

関節内補充療法市場は、変形性膝関節症（OA）の有病率の上昇や、非外科的治療オプションに対する需要の増加により、大きな成長を遂げています。関節内補充療法は、ヒアルロン酸を膝関節に注入して痛みを和らげ、可動性を改善するもので、軽度から中等度のOA患者に広く受け入れられています。この市場は、世界人口の高齢化、関節の健康に対する意識の高まり、そして利便性と有効性を高める単回注入型や架橋型などのヒアルロン酸製剤の進歩から恩恵を受けています。

人工関節置換術に代わる低侵襲治療の採用増加は、関節内補充療法市場拡大の主要促進要因の一つです。欧州や北米のような地域での好意的な償還政策や、新興国における医療アクセスの改善が、市場需要をさらに押し上げています。技術進歩と、より効果的な製剤の継続的な研究は、既存企業と新規参入企業の双方に大きな市場機会をもたらしています。

関節内補充療法市場は持続的な市場成長の態勢を整えており、主要企業は技術革新と戦略的提携に投資して、進化する患者ニーズに対応し、新たな機会を活用することで、変形性関節症管理に不可欠な要素としての役割を強化しています。

市場の見通しは明るく、高齢者人口の増加、可処分所得の増加、医療インフラの充実を背景に、アジア太平洋での力強い成長が期待されます。しかし、価格圧力、代替治療との競合、規制上のハードルといった課題は依然として残っています。

関節内補充療法市場：分析概要

製品別では、変形性膝関節症の管理において、その有効性が確立され、広く入手可能であり、医療提供者の間で好まれていることから、2024年には3回注射式が最大の市場シェアを占めました。

最終用途別では整形外科クリニック／ASCセグメントが、これらの環境で提供される専門的で費用対効果が高く、低侵襲の治療に対する患者の嗜好の高まりにより、予測期間中に最も速い成長が見込まれます。

2024年には、アジア太平洋は高齢化人口が多く、変形性膝関節症の有病率が増加しているため、関節内補充療法市場で最大のシェアを占めています。

欧州の関節内補充療法市場は、高度な変形性関節症治療に対する需要の増加により、予測期間中に最も速いCAGRを記録すると予想されています。

世界の主要企業には、Anika Therapeutics, Inc.、DePuy Synthes、F. Hoffmann-La Roche Ltd.、Ferring Pharmaceuticals B.V.、Fidia Farmaceutici S.p.A、LG Life Sciences Ltd.、Lifecore Biomedical、Sanofi、生化学工業、スミス・アンド・ネフューPLC、Zimmer Biometなどがあります。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 分析手法

第4章 関節内補充療法市場の洞察

  • 市場スナップショット
  • 関節内補充療法の市場力学
    • 促進要因と機会
      • 膝関節症の罹患率の上昇
      • 高齢化人口の増加
    • 抑制要因と課題
      • 高額な治療費
  • PESTLE分析
  • 関節内補充療法市場の動向：用途別
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界の関節内補充療法市場：製品別

  • 主な調査結果
  • イントロダクション
  • 3回注射式
  • 5回注射式
  • 単回注射式

第6章 世界の関節内補充療法市場：最終用途別

  • 主な調査結果
  • イントロダクション
  • 整形外科クリニック/外来手術センター (ASC)
  • 病院

第7章 世界の関節内補充療法市場：地域別

  • 主な分析結果
  • イントロダクション
    • 関節内補充療法市場の評価：地域別 (2020～2034年)
  • 北米
    • 北米：製品別 (2020～2034年)
    • 北米：最終用途別 (2020～2034年)
    • 米国
    • カナダ
  • 欧州
    • 欧州：製品別 (2020～2034年)
    • 欧州：最終用途別 (2020～2034年)
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋
    • アジア太平洋：製品別 (2020～2034年)
    • アジア太平洋：最終用途別 (2020～2034年)
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ
    • 中東・アフリカ：製品別 (2020～2034年)
    • 中東・アフリカ：最終用途別 (2020～2034年)
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ
  • ラテンアメリカ
    • ラテンアメリカ：製品別 (2020～2034年)
    • ラテンアメリカ：最終用途別 (2020～2034年)
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第8章 競合情勢

  • 事業拡大・企業買収の分析
    • 事業拡大
    • 企業買収
  • 提携/協業/合意/公開

第9章 企業プロファイル

  • Anika Therapeutics, Inc.
  • DePuy Synthes
  • F.Hoffmann-La Roche Ltd.
  • Ferring Pharmaceuticals B.V.
  • Fidia Farmaceutici S.p.A
  • LG Life Sciences Ltd.
  • Lifecore Biomedical
  • Sanofi
  • Seikagaku Corp.
  • Smith & Nephew PLC
  • Zimmer Biomet
図表

List of Tables:

  • Table 1 Global Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  • Table 2 Global Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
  • Table 3 North America: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  • Table 4 North America: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
  • Table 5 U.S.: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  • Table 6 U.S.: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
  • Table 7 Canada: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  • Table 8 Canada: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
  • Table 9 Europe: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  • Table 10 Europe: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
  • Table 11 UK: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  • Table 12 UK: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
  • Table 13 France: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  • Table 14 France: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
  • Table 15 Germany: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  • Table 16 Germany: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
  • Table 17 Italy: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  • Table 18 Italy: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
  • Table 19 Spain: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  • Table 20 Spain: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
  • Table 21 Netherlands: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  • Table 22 Netherlands: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
  • Table 23 Russia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  • Table 24 Russia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
  • Table 25 Rest of Europe: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  • Table 26 Rest of Europe: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
  • Table 27 Asia Pacific: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  • Table 28 Asia Pacific: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
  • Table 29 China: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  • Table 30 China: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
  • Table 31 India: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  • Table 32 India: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
  • Table 33 Malaysia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  • Table 34 Malaysia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
  • Table 35 Japan: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  • Table 36 Japan: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
  • Table 37 Indonesia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  • Table 38 Indonesia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
  • Table 39 South Korea: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  • Table 40 South Korea: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
  • Table 41 Australia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  • Table 42 Australia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
  • Table 43 Rest of Asia Pacific: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  • Table 44 Rest of Asia Pacific: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
  • Table 45 Middle East & Africa: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  • Table 46 Middle East & Africa: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
  • Table 47 Saudi Arabia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  • Table 48 Saudi Arabia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
  • Table 49 UAE: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  • Table 50 UAE: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
  • Table 51 Israel: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  • Table 52 Israel: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
  • Table 53 South Africa: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  • Table 54 South Africa: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
  • Table 55 Rest of Middle East & Africa: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  • Table 56 Rest of Middle East & Africa: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
  • Table 57 Latin America: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  • Table 58 Latin America: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
  • Table 59 Mexico: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  • Table 60 Mexico: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
  • Table 61 Brazil: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  • Table 62 Brazil: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
  • Table 63 Argentina: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  • Table 64 Argentina: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
  • Table 65 Rest of Latin America: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  • Table 66 Rest of Latin America: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Viscosupplementation Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Viscosupplementation Market, by Product, 2024 & 2034 (USD Billion)
  • Figure 8. Market by End Use
  • Figure 9. Global Viscosupplementation Market, by End Use, 2024 & 2034 (USD Billion)
目次
Product Code: PM1015

The global viscosupplementation market size is expected to reach USD 15.26 billion by 2034, according to a new study by Polaris Market Research. The report "Viscosupplementation Market Size, Share, Trends, Industry Analysis Report: By Product (Three Injection, Five Injection, and Single Injection), End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The viscosupplementation market is experiencing significant growth, driven by the rising prevalence of knee osteoarthritis (OA) and increasing demand for non-surgical treatment options. Viscosupplementation, which involves injecting hyaluronic acid into the knee joint to alleviate pain and improve mobility, has gained widespread acceptance among patients with mild to moderate OA. The market is benefitting from an aging global population, growing awareness of joint health, and advancements in hyaluronic acid formulations, such as single-injection and cross-linked variants, which enhance convenience and efficacy.

The increasing adoption of minimally invasive treatments that offer an alternative to joint replacement surgery is one of the key drivers of the viscosupplementation market expansion. Favorable reimbursement policies in regions like Europe and North America, along with improving healthcare access in emerging economies, have further boosted market demand. Technological advancements and ongoing research into more effective formulations present significant market opportunities for both established players and new entrants.

The viscosupplementation market is poised for sustained market growth, with key players investing in innovation and strategic partnerships to address evolving patient needs and capitalize on emerging opportunities, reinforcing its role as a vital component of osteoarthritis management.

The market outlook is positive, with robust growth expected in Asia Pacific, driven by large elderly populations, rising disposable income, and enhanced healthcare infrastructure. However, challenges such as pricing pressure, competition from alternative treatments, and regulatory hurdles remain.

Key Highlights of Viscosupplementation Market Report

In terms of product, in 2024, the three injection segment accounted for the largest market share due to its established efficacy, widespread availability, and preference among healthcare providers for managing knee osteoarthritis.

Based on end use, the orthopedic clinics/ASCs segment is expected to witness the fastest growth during the forecast period due to increasing patient preference for specialized, cost-effective, and minimally invasive treatments offered in these settings.

In 2024, Asia Pacific accounted for the largest share of the viscosupplementation market due to the region's large aging population and increasing prevalence of knee osteoarthritis.

The Europe viscosupplementation market is expected to witness the fastest CAGR during the forecast period due to increasing demand for advanced osteoarthritis treatments.

A few global key market players include Anika Therapeutics, Inc.; DePuy Synthes; F. Hoffmann-La Roche Ltd.; Ferring Pharmaceuticals B.V.; Fidia Farmaceutici S.p.A, LG Life Sciences Ltd.; Lifecore Biomedical; Sanofi; Seikagaku Corp.; Smith & Nephew PLC; and Zimmer Biomet.

Polaris Market Research has segmented the viscosupplementation market research report on the basis of product, end use, and region:

By Product Outlook (Revenue - USD Billion, 2020-2034)

  • Three Injection
  • Five Injection
  • Single Injection

By End Use Outlook (Revenue - USD Billion, 2020-2034)

  • Orthopedic Clinics/ASCs
  • Hospitals

By Regional Outlook (Revenue - USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Viscosupplementation Market Insights

  • 4.1. Viscosupplementation Market - Market Snapshot
  • 4.2. Viscosupplementation Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Prevalence of Knee Osteoarthritis
      • 4.2.1.2. Growing Aging Population
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Treatment Costs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Viscosupplementation Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Viscosupplementation Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  • 5.3. Three Injection
    • 5.3.1. Global Viscosupplementation Market, by Three Injection, by Region, 2020-2034 (USD Billion)
  • 5.4. Five Injection
    • 5.4.1. Global Viscosupplementation Market, by Five Injection, by Region, 2020-2034 (USD Billion)
  • 5.5. Single Injection
    • 5.5.1. Global Viscosupplementation Market, by Single Injection, by Region, 2020-2034 (USD Billion)

6. Global Viscosupplementation Market, by End Use

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
  • 6.3. Orthopedic Clinics/ASCs
    • 6.3.1. Global Viscosupplementation Market, by Orthopedic Clinics/ASCs, by Region, 2020-2034 (USD Billion)
  • 6.4. Hospitals
    • 6.4.1. Global Viscosupplementation Market, by Hospitals, by Region, 2020-2034 (USD Billion)

7. Global Viscosupplementation Market, by Geography

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Viscosupplementation Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 7.3. Viscosupplementation Market - North America
    • 7.3.1. North America: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
    • 7.3.2. North America: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
    • 7.3.3. Viscosupplementation Market - U.S.
      • 7.3.3.1. U.S.: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
      • 7.3.3.2. U.S.: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
    • 7.3.4. Viscosupplementation Market - Canada
      • 7.3.4.1. Canada: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
      • 7.3.4.2. Canada: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
  • 7.4. Viscosupplementation Market - Europe
    • 7.4.1. Europe: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
    • 7.4.2. Europe: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.3. Viscosupplementation Market - UK
      • 7.4.3.1. UK: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
      • 7.4.3.2. UK: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.4. Viscosupplementation Market - France
      • 7.4.4.1. France: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
      • 7.4.4.2. France: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.5. Viscosupplementation Market - Germany
      • 7.4.5.1. Germany: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
      • 7.4.5.2. Germany: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.6. Viscosupplementation Market - Italy
      • 7.4.6.1. Italy: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
      • 7.4.6.2. Italy: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.7. Viscosupplementation Market - Spain
      • 7.4.7.1. Spain: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
      • 7.4.7.2. Spain: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.8. Viscosupplementation Market - Netherlands
      • 7.4.8.1. Netherlands: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
      • 7.4.8.2. Netherlands: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.9. Viscosupplementation Market - Russia
      • 7.4.9.1. Russia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
      • 7.4.9.2. Russia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.10. Viscosupplementation Market - Rest of Europe
      • 7.4.10.1. Rest of Europe: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
      • 7.4.10.2. Rest of Europe: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
  • 7.5. Viscosupplementation Market - Asia Pacific
    • 7.5.1. Asia Pacific: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
    • 7.5.2. Asia Pacific: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.3. Viscosupplementation Market - China
      • 7.5.3.1. China: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
      • 7.5.3.2. China: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.4. Viscosupplementation Market - India
      • 7.5.4.1. India: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
      • 7.5.4.2. India: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.5. Viscosupplementation Market - Malaysia
      • 7.5.5.1. Malaysia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
      • 7.5.5.2. Malaysia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.6. Viscosupplementation Market - Japan
      • 7.5.6.1. Japan: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
      • 7.5.6.2. Japan: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.7. Viscosupplementation Market - Indonesia
      • 7.5.7.1. Indonesia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
      • 7.5.7.2. Indonesia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.8. Viscosupplementation Market - South Korea
      • 7.5.8.1. South Korea: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
      • 7.5.8.2. South Korea: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.9. Viscosupplementation Market - Australia
      • 7.5.9.1. Australia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
      • 7.5.9.2. Australia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.10. Viscosupplementation Market - Rest of Asia Pacific
      • 7.5.10.1. Rest of Asia Pacific: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
      • 7.5.10.2. Rest of Asia Pacific: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
  • 7.6. Viscosupplementation Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
    • 7.6.2. Middle East & Africa: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
    • 7.6.3. Viscosupplementation Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
    • 7.6.4. Viscosupplementation Market - UAE
      • 7.6.4.1. UAE: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
      • 7.6.4.2. UAE: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
    • 7.6.5. Viscosupplementation Market - Israel
      • 7.6.5.1. Israel: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
      • 7.6.5.2. Israel: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
    • 7.6.6. Viscosupplementation Market - South Africa
      • 7.6.6.1. South Africa: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
      • 7.6.6.2. South Africa: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
    • 7.6.7. Viscosupplementation Market - Rest of Middle East & Africa
      • 7.6.7.1. Rest of Middle East & Africa: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
      • 7.6.7.2. Rest of Middle East & Africa: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
  • 7.7. Viscosupplementation Market - Latin America
    • 7.7.1. Latin America: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
    • 7.7.2. Latin America: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
    • 7.7.3. Viscosupplementation Market - Mexico
      • 7.7.3.1. Mexico: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
      • 7.7.3.2. Mexico: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
    • 7.7.4. Viscosupplementation Market - Brazil
      • 7.7.4.1. Brazil: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
      • 7.7.4.2. Brazil: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
    • 7.7.5. Viscosupplementation Market - Argentina
      • 7.7.5.1. Argentina: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
      • 7.7.5.2. Argentina: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
    • 7.7.6. Viscosupplementation Market - Rest of Latin America
      • 7.7.6.1. Rest of Latin America: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
      • 7.7.6.2. Rest of Latin America: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Anika Therapeutics, Inc.
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. DePuy Synthes
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. F.Hoffmann-La Roche Ltd.
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Ferring Pharmaceuticals B.V.
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Fidia Farmaceutici S.p.A
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. LG Life Sciences Ltd.
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Lifecore Biomedical
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Sanofi
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Seikagaku Corp.
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Smith & Nephew PLC
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Zimmer Biomet
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development